 |
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
AEterna Zentaris Subsidiary Atrium Biotechnologies Acquires Canadian Business Multichem27 Jan 2005 - AEterna Zentaris Inc. announced the closing of the acquisition of all Multichem assets by its subsidiary Atrium Biotechnologies Inc., for the total amount of 23.8 million canadian dollars of which 22.2 million canadian dollars were paid in cash at the closing. This acquisition was financed through Atrium's working capital, as well as from a new banking credit facility. Multichem is a privately-heldAdditional information
News regarding Business |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Product of the Week |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
 Top |
|||
Contact
Print version
PDF version
Send article
RSS feed
